MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in MAIA Biotechnology, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q4 2024
- Shares held
- 1.48M
- +86.3K (+6.2%) vs. Q4 2024
- Total value
- $2.26M
- −$493.0K (−17.9%) vs. Q4 2024
- New holders
- 3
- 6 more added
- Sold out
- 3
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MAIA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $19.4M |
| Q1 2026 | 33 | $18.4M |
| Q4 2025 | 26 | $4.09M |
| Q3 2025 | 19 | $3.49M |
| Q2 2025 | 20 | $3.95M |
| Q1 2025 | 20 | $2.26M |
| Q4 2024 | 20 | $2.75M |
| Q3 2024 | 17 | $4.15M |
| Q2 2024 | 21 | $6.09M |
| Q1 2024 | 20 | $1.50M |
| Q4 2023 | 22 | $957.8K |
| Q3 2023 | 14 | $699.6K |
| Q2 2023 | 12 | $709.1K |
| Q1 2023 | 6 | $246.7K |
| Q4 2022 | 6 | $1.04M |
| Q3 2022 | 9 | $763.0K |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding MAIA Biotechnology, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 650,256 | $994.9K | 0.00% | +67,749+11.6% | Added |
| Halter Ferguson Financial Inc. | 237,356 | $363.2K | 0.20% | −3,462−1.4% | Reduced |
| Geode Capital Management, LLC | 214,437 | $328.2K | 0.00% | +16,913+8.6% | Added |
| BlackRock, Inc. | 84,083 | $128.6K | 0.00% | −702−0.8% | Reduced |
| Centric Wealth Management | 68,248 | $104.4K | 0.03% | +290.0% | Added |
| Susquehanna International Group, LLP | 55,100 | $84.3K | 0.00% | +43,451+373.0% | Added |
| State Street Corp | 53,250 | $81.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 39,032 | $59.7K | 0.00% | +6,961+21.7% | Added |
| Bridgeway Capital Management, LLC | 36,000 | $55.1K | 0.00% | −9,700−21.2% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 14,800 | $22.6K | 0.00% | 00.0% | Unchanged |
| Naviter Wealth, LLC | 10,000 | $16.2K | 0.00% | +10,000 | New |
| Advisor Group Holdings, Inc. | 7,450 | $11.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,095 | $7.79K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 675 | $1.03K | 0.00% | 00.0% | Unchanged |
| Bernard Wealth Management Corp. | 500 | $765 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 300 | $459 | 0.00% | +300 | New |
| Jones Financial Companies LLLP | 228 | $369 | 0.00% | +228 | New |
| Tower Research Capital LLC (TRC) | 239 | $366 | 0.00% | −3,046−92.7% | Reduced |
| Bank of America Corp | 179 | $274 | 0.00% | +15+9.1% | Added |
| JPMorgan Chase & Co | 42 | $64 | 0.00% | −3−6.7% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −39,057−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −341−100.0% | Sold out |